glp-1 receptor agonist type 1 diabetes trial liraglutide SGLT2i and RA therapy in and reno-vascular outcomes: a real-world study | Diabetologia A System-Based Review on Effects
Description
Biomolecules (2019) 10(1):40
10.1016/j.neulet.2015.12.007 Neurosci
Phloretin suppresses carbohydrate-induced GLP-1 secretion via inhibiting short chain fatty acid release from gut microbiome
Abbreviations BMI, Body mass index
Effects of glucagonlike peptide1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
Saxenda should be injected into the thigh, abdomen, or upper arm
